PSA is a validated FDA-recognized clinical endpoint in assessing prostate cancer treatment response; Telomir-1 lowered PSA ...

A study co-led by investigators at the UCLA Health Jonsson Comprehensive Cancer Center found that most of the benefits of ...

New hope for advanced prostate cancer patients, with promising new drug combo that targets genes, such as BRCA1, BRCA2, CHEK2, and PALB2.

A new study has uncovered promising therapeutic strategies against one of the deadliest forms of prostate cancer.

Oncologists and urologists identified several barriers to treatment intensification for metastatic castration-sensitive ...

It sounds deceptively simple. Develop a better prostate cancer treatment by super charging the body's own natural killer ...

In this meta-analysis, researchers evaluated the use and/or prolongation of ADT in men with non-metastatic prostate cancer undergoing definitive radiotherapy.

Scientists have uncovered a critical weakness in prostate cancer’s defences. The disease relies on two enzymes, PDIA1 and PDIA5, to survive and resist treatment. When these enzymes are blocked, cancer ...

Men diagnosed with prostate cancer have traditionally faced two choices: Do nothing and hope the tumor doesn’t grow between ...

Prostate cancer has become a significant health concern among men, being the second leading cause of death in the United States. While the survival rate in men remains high, those who have advanced, ...

David Cameron has revealed he battled prostate cancer and is backing calls for targeted screening for men at highest risk of ...